TipRanks
Innate Pharma (DE:IDDA)
FRANKFURT:IDDA
Germany Market
IDDA
Innate Pharma
RESEARCH TOOLSreports

Innate Pharma (IDDA) Cash flow

1 Followers

Innate Pharma Cash Flow

DE:IDDA's free cash flow for Q4 2025 was €-23.48M. For the 2025 fiscal year, DE:IDDA's free cash flow was decreased by €-27.62M and operating cash flow was €-23.40M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
€ -32.56M€ -6.90M€ -32.56M€ -19.15M€ -58.46M
Investing Cash Flow
€ 20.63M€ 9.20M€ 20.63M€ 1.88M€ -917.00K
Financing Cash Flow
€ -1.97M€ -6.01M€ -1.97M€ -1.83M€ 26.82M
End Cash Position
€ 70.61M€ 66.40M€ 70.61M€ 84.22M€ 103.76M
Free Cash Flow
€ -34.91M€ -7.29M€ -34.91M€ -20.28M€ -59.79M
Currency in EUR

Innate Pharma Cash Flow